uPAR: a versatile signalling orchestrator (original) (raw)

• Collen, D. The plasminogen (fibrinolytic) system. Thromb. Haemost. 82, 259–270 (1999).
  CAS PubMed Google Scholar
• Appella, E. et al. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J. Biol. Chem. 262, 4437–4440 (1987).
  CAS PubMed Google Scholar
• Ploug, M. & Ellis, V. Structure–function relationship in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom a-neurotoxins. FEBS Lett. 349, 163–168 (1994).
  CAS PubMed Google Scholar
• Behrendt, N., Roenne, E. & Danoe, K. Domain interplay in the urokinase receptor-requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains. J. Biol. Chem. 271, 22885–22894 (1996).
  CAS PubMed Google Scholar
• Ploug, M. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site. Biochemistry 37, 16494–16505 (1998).
  CAS PubMed Google Scholar
• Waltz, D. A. & Chapman, H. A. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269, 14746–14750 (1994).
  CAS PubMed Google Scholar
• Loskutoff, D. J., Curriden, S. A., Hu, G. & Deng, G. Regulation of cell adhesion by PAI-1. Apmis. 107, 54–61 (1999).
  CAS PubMed Google Scholar
• Nykjær, A. et al. Purified a2-macroglobulin receptor/LDL receptor-related protein binds urokinase-plasminogen activcator inhibitor type-1 complex. Evidence that the a2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543–14546 (1992).
  PubMed Google Scholar
• Czekay, R. P., Kuemmel, T. A., Orlando, R. A. & Farquhar, M. G. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol. Biol. Cell 12, 1467–1479 (2001).
  CAS PubMed PubMed Central Google Scholar
• Nykjær, A. et al. Recycling of the urokinase receptor during internalization of the uPA–serpin complexes. EMBO J. 16, 2610–2620 (1997).
  PubMed PubMed Central Google Scholar
• Sidenius, N., Andolfo, A., Fesce, R. & Blasi, F. Urokinase regulates vitronectin binding in vitro and in vivo by controlling urokinase receptor oligomerization. J. Biol. Chem. 277, 27982–27990 (2002).
  CAS PubMed Google Scholar
• Resnati, M. et al. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15, 1572–1582 (1996).
  CAS PubMed PubMed Central Google Scholar
• Giancotti, F. G. & Ruoslahti, E. Integrin signaling. Science 285, 1028–1032 (1999).
  Article CAS PubMed Google Scholar
• Wei, Y. et al. Regulation of integrin function by the urokinase receptor. Science 273, 1551–1555 (1996). This paper discusses a molecular basis for the mechanism by which uPAR can regulate signalling, by showing a direct interaction between uPAR and integrins.
  CAS PubMed Google Scholar
• Yebra, M. et al. Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J. Biol. Chem. 271, 29393–29399 (1996).
  CAS PubMed Google Scholar
• Degryse, B., Orlando, S., Resnati, M., Rabbani, S. A. & Blasi, F. Urokinase/urokinase receptor and vitronectin/avb3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways. Oncogene 20, 2032–2043 (2001).
  CAS PubMed Google Scholar
• May, A. E. et al. Urokinase receptor (CD87) regulates leukocyte recruitment via β2 integrins in vivo. J. Exp. Med. 188, 1029–1037 (1998). This paper reports a role of uPAR as a signalling receptor in leukocyte recruitment.
  CAS PubMed PubMed Central Google Scholar
• Waltz, D. A. et al. Nonproteolytic role for the urokinase receptor in cellular migration in vivo. Am. J. Respir. Cell. Mol. Biol. 22, 316–322 (2000).
  CAS PubMed Google Scholar
• Bohuslav, J. et al. Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181, 1381–1390 (1995).
  CAS PubMed Google Scholar
• Aguirre Ghiso, J. A., Kovalski, K. & Ossowski, L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147, 89–104 (1999).
  CAS PubMed Google Scholar
• Carriero, M. V. et al. Urokinase receptor interacts with α(v)β5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res. 59, 5307–5314 (1999).
  CAS PubMed Google Scholar
• Tarui, T., Mazar, A. P., Cines, D. B. & Takada, Y. Urokinase receptor (uPAR/CD87) is a ligand for integrin and mediates cell–cell interaction. J. Biol. Chem. 276, 3983–3990 (2000).
  PubMed Google Scholar
• Simon, D. I. et al. Identification of a urokinase receptor–integrin interaction site. Promiscuous regulator of integrin function. J. Biol. Chem. 275, 10228–10234 (2000).
  CAS PubMed Google Scholar
• Wei, Y., Eble, J. A., Wang, Z., Kreidberg, J. A. & Chapman, H. A. Urokinase receptor promotes b1 integrin function through interactions with integrin a3b1. Mol. Biol. Cell 12, 2975–2986 (2001).
  CAS PubMed PubMed Central Google Scholar
• Liu, D., Aguirre-Ghiso, J. A., Estrada, Y. & Ossowski, L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1, 445–457 (2002).
  CAS PubMed Google Scholar
• Montuori, N., Carriero, M. V., Salzano, S., Rossi, G. & Ragno, P. The cleavage of the urokinase receptor regulates its multiple functions. J. Biol. Chem. 2002 Sep 23 (DOI: 10.1074/jbc.M207494200).
• Fazioli, F. et al. The urokinase-sensitive region of the urokinase receptor is responsible for its potent chemotactic activity. EMBO J 16, 7279–7286 (1997). This paper identifies the chemotactic epitope of uPAR.
  CAS PubMed PubMed Central Google Scholar
• Degryse, B. et al. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis, and cytoskeleton reorganization in rat smooth muscle cells via the urokinase receptor. Blood 94, 649–662 (1999).
  CAS PubMed Google Scholar
• Nguyen, D. H. et al. Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps–Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J. Biol. Chem. 275, 19382–19388 (2000).
  CAS PubMed Google Scholar
• Resnati, M. et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl Acad. Sci. USA 99, 1359–1364 (2002). This study reports the interaction of uPAR with GPCR.
  CAS PubMed PubMed Central Google Scholar
• Le, Y. et al. A new insight in the role of 'old' chemotactic peptide receptor FPR and FPRL1: down-regulation opf chemokine receptors CCR5 and CXCR4. Forum 94, 299–311 (1999).
  Google Scholar
• Simons, K. & Toomre, D. Lipid rafts and signal transduction. Nature Rev. Mol. Cell Biol. 1, 31–39 (2000).
  CAS Google Scholar
• Wei, Y., Yang, X., Liu, Q., Wilkins, J. A. & Chapman, H. A. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J. Cell Biol. 144, 1285–1294 (1999).
  CAS PubMed PubMed Central Google Scholar
• Gomez-Mouton, C. et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc. Natl Acad. Sci. USA 98, 9642–9647 (2001). This paper shows the existence of two types of glycophospholipid raft (containing GM1 or GM3), and the segregation of uPAR with chemokine receptors in GM3 rafts that are present specifically at the leading edge of a migrating lymphocyte.
  CAS PubMed PubMed Central Google Scholar
• Koshelnick, Y., Ehart, M., Hufnagl, P., Heinrich, P. C. & Binder, B. R. Urokinase receptor is associated with the components of the JAK:STAT1 signaling pathway and leads to the activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J. Biol. Chem. 272, 28563–28567 (1997).
  CAS PubMed Google Scholar
• Weaver, A. M., Hussaini, I. M., Mazar, A., Henkin, J. & Gonias, S. L. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J. Biol. Chem. 272, 14372–14379 (1997).
  CAS PubMed Google Scholar
• Webb, D. J., Nguyen, D. H., Sankovic, M. & Gonias, S. L. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J. Biol. Chem. 274, 7412–7420 (1999).
  CAS PubMed Google Scholar
• Degryse, B., Sier, C. F. M., Resnati, M., Conese, M. & Blasi, F. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor. FEBS Lett. 505, 249–254 (2001).
  CAS PubMed Google Scholar
• Nykjaer, A. et al. Mannose-6-phosphate/insulin like growth factor II receptor targets the urokinase receptor to lysosomes via a novel binding interaction. J. Cell Biol. 141, 815–828 (1998).
  CAS PubMed PubMed Central Google Scholar
• Behrendt, N. et al. A urokinase receptor-associated protein with specific collagen binding properties. J. Biol. Chem. 275, 1993–2002 (2000).
  CAS PubMed Google Scholar
• Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K. & Ossowski, L. Urokinase receptor and fibronectin regulate the ERK (MAPK) to p38 (MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell 12, 863–879 (2001). This paper identifies the integrin as the target of uPAR in uPAR-dependent cell proliferation, and the requirement of this interaction for cell growth.
  CAS PubMed PubMed Central Google Scholar
• Webb, D. J., Nguyen, D. H. & Gonias, S. L. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and Matrigel invasion. J. Cell Sci. 113, 123–134 (2000).
  CAS PubMed Google Scholar
• Kjoeller, L. & Hall, A. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152, 1145–1157 (2001).
  Google Scholar
• Nguyen, D. H. et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. 146, 149–164 (1999).
  CAS PubMed PubMed Central Google Scholar
• Busso, N., Masur, S. K., Lazega, D., Waxman, S. & Ossowski, L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126, 259–270 (1994).
  CAS PubMed Google Scholar
• Myohanen, H. T. et al. Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J. Histochem. Cytochem. 41, 1291–1301 (1993).
  CAS PubMed Google Scholar
• Sitrin, R. G., Pan, P. M., Harper, H. A., Blackwood, R. A. & Todd, R. F. Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes. J. Immunol. 163, 6193–6200 (1999).
  CAS PubMed Google Scholar
• Sitrin, R. G., Pan, P. M., Blackwood, R. A., Huang, J. & Petty, H. R. Evidence for a signaling partnership between urokinase receptors (cd87) and l-selectin (cd621) in human polymorphonuclear neutrophils. J. Immunol. 166, 4822–4825 (2001).
  CAS PubMed Google Scholar
• Le, Y. et al. Amyloid (β)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123 (2001).
  CAS PubMed PubMed Central Google Scholar
• Dumler, I. et al. The JAK/STAT pathway and urokinase receptor signaling in human aortin vascular smooth muscle cells. J. Biol. Chem. 273, 315–321 (1998).
  CAS PubMed Google Scholar
• Wang, N., Planus, E., Pouchelet, M., Fredberg, J. J. & Barlovatz-Meimon, G. Urokinase receptor mediates mechanical force transfer across the cell surface. Am. J. Physiol. 268, C1062–C1066 (1995).
  CAS PubMed Google Scholar
• Kusch, A. et al. Urokinase stimulates human vascular smooth muscle cells migration via a phosphatidylinositol 3-kinase-tyk2 interaction. J. Biol. Chem. 275, 39466–39473 (2000).
  CAS PubMed Google Scholar
• Sidenius, N. & Blasi, F. Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin. FEBS Lett. 470, 40–46 (2000).
  CAS PubMed Google Scholar
• Stepanova, V. et al. Urokinase-dependent human vascular smooth muscle cells adhesion requires selective vitronectin phorphorylation by ecto-protein kinase CK2. J. Biol. Chem. 277, 10265–10272 (2002).
  CAS PubMed Google Scholar
• Simon, D. I. et al. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 88, 3185–3194 (1996).
  CAS PubMed Google Scholar
• Nusrat, A. R. & Chapman, H. A. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87, 1091–1097 (1991).
  CAS PubMed PubMed Central Google Scholar
• Ferias-Eisner, R. et al. Thye urokinase plasminogen activator receptor (uPAR) is preferentially induced by nerve growth factors in PC12 pheomocromocytoma cells and is required for NGF-driven differentiation. J. Neurosci. 20, 230–239 (2000).
  Google Scholar
• Rabbani, S. A. et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267, 14151–14156 (1992).
  CAS PubMed Google Scholar
• Kirchheimer, J. C., Wojta, J., Christ, G., Hienert, G. & Binder, B. R. Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J. 1, 125–128 (1987).
  CAS PubMed Google Scholar
• Yu, W., Kim, J. & Ossowski, L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J. Cell Biol. 137, 767–777 (1997).
  CAS PubMed PubMed Central Google Scholar
• Carmeliet, P. et al. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J. Cell Biol. 140, 233–245 (1998). This paper provides a possible explanation for the redundant role of uPAR as protease receptor, in part because uPA binds other ECM components.
  CAS PubMed PubMed Central Google Scholar
• Chiaradonna, F. et al. Urokinase receptor-dependent and -independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J. 11, 3013–3023 (1999).
  Google Scholar
• Kook, Y. H., Adamski, J., Zelent, A. & Ossowski, L. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy. EMBO J. 13, 3983–3991 (1994).
  CAS PubMed PubMed Central Google Scholar
• Luttun, A., Dewerchin, M., Collen, D. & Carmeliet, P. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies. Curr. Atheroscler. Rep. 2, 407–416 (2000).
  CAS PubMed Google Scholar
• Degen, J. L. Genetic interactions between the coagulation and fibrinolytic systems. Thromb. Haemost. 86, 130–137 (2001).
  CAS PubMed Google Scholar
• Eitzman, D. T. & Ginsburg, D. Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo. Adv. Exp. Med. Biol. 425, 131–141 (1997).
  CAS PubMed Google Scholar
• Carmeliet, P. et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 369, 419–424 (1994). The first study of a proteinase knockout in mice, reporting the crucial role of tPA and uPA in normal health.| PubMed |
  Google Scholar
• Bugge, T. H. et al. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270, 16886–16894 (1995). This paper reports the normal phenotype of uPAR-deficient mice.
  CAS PubMed Google Scholar
• Dewerchin, M. et al. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97, 870–878 (1996). This paper reports the normal phenotype of uPAR-deficient mice.
  CAS PubMed PubMed Central Google Scholar
• Ploplis, V. A. et al. Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 92, 2585–2593 (1995).
  CAS PubMed Google Scholar
• Bugge, T. H., Flick, M. J., Daugherty, C. C. & Degen, J. L. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794–807 (1995).
  CAS PubMed Google Scholar
• Bugge, T. H. et al. Loss of fibrinogen rescues mice from pleiotropic effects of plasminogen deficiency. Cell 87, 709–719 (1996).
  CAS PubMed Google Scholar
• Bugge, T. H. et al. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl Acad. Sci. USA 93, 5899–5904 (1996). This study reports that uPAR is redundant as a protease receptor in fibrin surveillance.
  CAS PubMed PubMed Central Google Scholar
• Carmeliet, P. & Collen, D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb. Res. 91, 255–285 (1998).
  CAS PubMed Google Scholar
• Carmeliet, P. et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genet. 17, 439–444 (1997). This paper reports that matrix metalloproteinases are activated by uPA-generated plasmin in vivo.
  CAS PubMed Google Scholar
• Moons, L. et al. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J. Clin. Invest. 102, 1788–1797 (1998).
  CAS PubMed PubMed Central Google Scholar
• Carmeliet, P. et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81, 829–839 (1997).
  CAS PubMed Google Scholar
• Heymans, S. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature Med. 5, 1135–1142 (1999). This paper reports that loss of uPA, but not uPAR, prevents destruction of the ischaemic myocardium, thereby showing a redundant role of uPAR as a proteinase receptor.
  CAS PubMed Google Scholar
• Lund, L. R. et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J. 18, 4645–4656 (1999).
  CAS PubMed PubMed Central Google Scholar
• Romer, J. et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med. 2, 287–292 (1996).
  CAS PubMed Google Scholar
• Bajou, K. et al. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Med. 4, 923–928 (1998).
  CAS PubMed Google Scholar
• Bajou, K. et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J. Cell Biol. 152, 777–784 (2001). This paper reports a redundant role of host uPAR in tumour vascularization.
  CAS PubMed PubMed Central Google Scholar
• Carmeliet, P., Moons, L., Ploplis, V., Plow, E. & Collen, D. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99, 200–208 (1997).
  CAS PubMed PubMed Central Google Scholar
• Levi, M. et al. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice. Circulation 103, 2014–2020 (2001).
  CAS PubMed Google Scholar
• Soriano, S. G. et al. Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 30, 134–139 (1999).
  CAS PubMed Google Scholar
• Gyetko, M. R. et al. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165, 1513–1519 (2000). This paper reports a role of uPAR as a signalling receptor in neutrophil recruitment.
  CAS PubMed Google Scholar
• Metzler, B. et al. Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1. Cardiovasc. Res. 49, 399–407 (2001).
  CAS PubMed Google Scholar
• Bunting, M., Harris, E. S., McIntyre, T. M., Prescott, S. M. & Zimmerman, G. A. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving β2 integrins and selectin ligands. Curr. Opin. Hematol. 9, 30–35 (2002).
  PubMed Google Scholar
• Gyetko, M. R. et al. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J. Immunol. 167, 5539–5542 (2001).
  CAS PubMed Google Scholar
• Gyetko, M. R., Todd, R. F., Wilkinson, C. C. & Sitrin, R. G. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93, 1380–1387 (1994).
  CAS PubMed PubMed Central Google Scholar
• Rijneveld, A. W. et al. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J. Immunol. 168, 3507–3511 (2002).
  CAS PubMed Google Scholar
• Gyetko, M. et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest. 97, 1818–1826 (1996).
  CAS PubMed PubMed Central Google Scholar
• Jones, S. P. et al. Leukocyte and endothelial cell adhesion molecules in a chronic murine model of myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 279, 196–201 (2000).
  Google Scholar
• Alfano, M., Sidenius, N., Panzeri, B., Blasi, F. & Poli, G. Urokinase–urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc. Natl Acad. Sci. USA 99, 8862–8867 (2002).
  CAS PubMed PubMed Central Google Scholar
• Speth, C., Pichler, I., Stockl, G., Mair, M. & Dierich, M. P. Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 199, 152–162 (1998).
  CAS PubMed Google Scholar
• Coleman, J. L., Gebbia J. A. & Benach J. L. Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor. J. Immunol. 166, 473–480 (2001).
  CAS PubMed Google Scholar
• Sidenius, N. et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96, 4091–4095 (2000).
  CAS PubMed Google Scholar
• Florquin, S. et al. Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int. 59, 2054–2061 (2001).
  CAS PubMed Google Scholar
• Xue, W., Hashimoto, K. & Toi, Y. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis. J. Cutan Pathol. 25, 469–474 (1998).
  CAS PubMed Google Scholar
• Del Rosso, M., Fibbi, G. & Matucci Cerinic, M. The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin. Exp. Rheumatol. 17, 485–498 (1999).
  CAS PubMed Google Scholar
• Walker, D. G., Lue, L. F. & Beach, T. G. Increased expression of the urokinase plasminogen-activator receptor in amyloid β peptide-treated human brain microglia and in AD brains. Brain Res. 926, 69–79 (2002).
  CAS PubMed Google Scholar
• Okada, S. S. et al. Native atherosclerosis and vein graft arterialization: association with increased urokinase receptor expression in vitro and in viv. Thromb. Haemost. 80, 140–147 (1998).
  CAS PubMed Google Scholar
• Solberg, H., Ploug, M., Hoyer-Hansen, G., Nielsen, B. S. & Lund, L. R. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J. Histochem. Cytochem. 49, 237–246 (2001).
  CAS PubMed Google Scholar
• Bisgaard, H. C., Santoni-Rugiu, E., Nagy, P. & Thorgeirsson, S. S. Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells. Lab. Invest. 78, 237–246 (1998).
  CAS PubMed Google Scholar
• Stephens, R. W. et al. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J. Natl Cancer Inst. 91, 869–874 (1999). This paper shows that, in colon carcinoma patients, high serum levels of uPAR predict poor survival.
  CAS PubMed Google Scholar
• Crowley, C. W. et al. Prevention of metastasis by inhibition of the urokinase receptor. Proc. Natl Acad. Sci. USA 90, 5021–5025 (1993). In a human xenografted tumour model, co-expression of inhibitors of the uPA–uPAR interaction block metastasis.
  CAS PubMed PubMed Central Google Scholar
• Min, H. Y. et al. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 56, 2428–2433 (1996). Interference with the uPA—uPAR interaction blocks tumour angiogenesis and growth.
  CAS PubMed Google Scholar
• Stoppelli, M. P. et al. Autocrine saturation of pro-urokinase receptor on human A431 cells. Cell 45, 675–684 (1986).
  CAS PubMed Google Scholar
• Pyke, C. et al. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am. J. Pathol. 138, 1059–1067 (1991).
  CAS PubMed PubMed Central Google Scholar
• Brunner, N. et al. The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer. Apmis. 107, 160–167 (1999).
  CAS PubMed Google Scholar
• Lakka, S. S. et al. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clin. Cancer Res. 7, 1087–1093 (2001).
  CAS PubMed Google Scholar
• Ploug, M. et al. Peptide-derived antagonists of the urokinase receptor. Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation. Biochemistry 40, 12157–12168 (2001).
  CAS PubMed Google Scholar
• Pepper, M. S. Role of the matrix metalloproteinase and plasminogen activator–plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104–1117 (2001).
  CAS PubMed Google Scholar
• Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000).
  CAS PubMed Google Scholar
• Jain, R. K. & Carmeliet, P. F. Vessels of death or life. Sci. Am. 285, 38–45 (2001).
  CAS PubMed Google Scholar
• Thewes, M., Elsner, E., Wessner, D., Engst, R. & Ring, J. The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study. Int. J. Dermatol. 39, 188–191 (2000).
  CAS PubMed Google Scholar
• Fibbi, G. et al. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Lab. Invest. 78, 1109–1119 (1998).
  CAS PubMed Google Scholar
• Li, H. et al. Adenovirus mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice. Gene Ther. 5, 1105–1113 (1998).
  CAS PubMed Google Scholar
• Harbeck, N. et al. Clinical relevance of the plasminogen activator inhibitor type 1 — a multifaceted proteolytic factor. Onkologie 24, 238–244 (2001).
  CAS PubMed Google Scholar
• Lambert, V. et al. Influence of plasminogen activator inhibitor type-1 on choroidal neovascularization. FASEB J. 15, 1021–1027 (2001).
  CAS PubMed Google Scholar
• Gutierrez, L. S. et al. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res. 60, 5839–5847 (2000).
  CAS PubMed Google Scholar
• McMahon, G. A. et al. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem. 276, 33964–33968 (2001).
  CAS PubMed Google Scholar
• Stefansson, S. et al. Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1. J. Biol. Chem. 276, 8135–8141 (2001).
  CAS PubMed Google Scholar
• Devy, L. et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16, 147–154 (2002).
  CAS PubMed Google Scholar
• Ossowski, L. & Aguirre Ghiso, J. A. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr. Opin. Cell Biol. 12, 613–620 (2000). A thoughtful survey of the signalling pathways that are activated by uPAR.
  CAS PubMed Google Scholar
• Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease, J Pathol. 190, 387–405 (2000).
  CAS PubMed Google Scholar